Oscar Health (OSCR) Net Income towards Common Stockholders (2020 - 2026)

Oscar Health (OSCR) has 7 years of Net Income towards Common Stockholders data on file, last reported at $679.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 146.46% year-over-year to $679.0 million; the trailing twelve-month figure through Mar 2026 stood at -$39.4 million (down 131.73% YoY), and the FY2025 full-year result was -$442.9 million, down 1795.58% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $679.0 million, up from -$352.4 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $679.0 million in Q1 2026 and bottomed at -$352.4 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is -$77.3 million (2022), against an average of -$36.3 million.
• The widest annual swing landed in 2024, when Net Income towards Common Stockholders soared 547.87%; it then plunged 505.76% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$226.6 million in 2022, then surged by 33.86% to -$149.8 million in 2023, then retreated by 2.3% to -$153.3 million in 2024, then tumbled by 129.92% to -$352.4 million in 2025, then jumped by 292.67% to $679.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $679.0 million (Q1 2026), -$352.4 million (Q4 2025), and -$137.5 million (Q3 2025), per Business Quant data.

Peer Comparison